Search

David S Dresback

from Stonington, CT
Age ~81
Get Report
Also known as:
David D Dresback, Dave S Dresback
Phone and address:
21 Elm St, Stonington, CT 06378
(860) 535-1283
Related to:
Susan W Rabil, 68
Connected to:
Arnold B Dresbach, 91Dean Dresback, 96Lauren Dresbach, 37Andrea Dresch, 71Patricia P Dresch, 74Shannon E Dresch, 44Tristan C Dresch, 55Allen J Drescher, 36Barbara A Drescher, 69Catherine A Drescher, 56

David Dresback Phones & Addresses

  • 21 Elm St, Stonington, CT 06378 (860) 535-1283
  • Sarasota, FL
  • Riverside, CA

Resumes

Resumes

David Dresback Photo 1

Owner, Pr Pharma Consulting, Llc

View page
Position:
Owner at PR Pharma Consulting, LLC
Location:
New London/Norwich, Connecticut Area
Industry:
Pharmaceuticals
Work:
PR Pharma Consulting, LLC since 2002
Owner
PharmAdvisors 2002 - 2012
Consultant
Pfizer Global Research & Development 1974 - 2002
Senior Director
Pfizer 1974 - 2002
Senior Director
Education:
University of Michigan
Skills:
Pharmaceutical Industry
David Dresback Photo 2

David Dresback

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
David S. Dresback
PR PHARMA CONSULTING, LLC
21 Elm St, Stonington, CT 06378

Publications

Us Patents

Antimicrobial Compositions

View page
US Patent:
20120065186, Mar 15, 2012
Filed:
May 11, 2011
Appl. No.:
13/105513
Inventors:
Danping LI - Middlebury CT, US
Eric S. BURAK - East Haddam CT, US
David S. DRESBACK - Stonington CT, US
Danielle B. LORD - Hamden CT, US
International Classification:
A61K 31/4709
A61P 31/04
US Classification:
51421021
Abstract:
The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.

Controlled Release Delivery System

View page
US Patent:
42201535, Sep 2, 1980
Filed:
Feb 22, 1979
Appl. No.:
6/014388
Inventors:
David S. Dresback - Groton CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61M 700
US Classification:
128260
Abstract:
Delivery systems and devices for the controlled release of chemicals, including drugs, comprising a wall, formed in part at least, of a porous fabric material, pores of which contain a hydrogel, said porous wall in contact with at least a portion of a reservoir comprised of a chemical and, if desired, a water-soluble liquid excipient and/or a detergent; process for preparation thereof, and use for the controlled release of chemicals, including drugs, to an aqueous liquid-containing environment. Emphasis is given to said systems and devices in which the porous fabric material is a synthetic fabric and gelled cellulose triacetate is the hydrogel, and to their use for controlled release of drugs to animals, especially to ruminants, over prolonged periods of time.

Delivery System

View page
US Patent:
42201527, Sep 2, 1980
Filed:
Feb 22, 1979
Appl. No.:
6/014387
Inventors:
David S. Dresback - Groton CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61M 500
US Classification:
128260
Abstract:
Delivery systems and devices for the controlled release of chemicals, including drugs, comprising a wall, formed in part at least, of a porous material, pores of which contain a hydrogel, said porous wall in contact with at least a portion of a reservoir comprised of a chemical and, if desired, a water-soluble liquid excipient and/or a detergent; process for preparation thereof, and use for the controlled release of chemicals, including drugs, to an aqueous liquid-containing environment. Emphasis is given to said systems and devices in which the porous material is a sintered plastic and gelled cellulose triacetate is the hydrogel, and to their use for controlled release of drugs to animals, especially to ruminants over prolonged periods of time.

Antimicrobial Compositions

View page
US Patent:
20220265636, Aug 25, 2022
Filed:
Aug 18, 2021
Appl. No.:
17/405772
Inventors:
- Morristown NJ, US
Eric S. BURAK - East Haddam CT, US
David S. DRESBACK - Stonington CT, US
Danielle B. LORD - Hamden CT, US
International Classification:
A61K 31/4709
A61K 47/18
A61K 47/40
A61K 9/00
B82Y 5/00
A61K 31/47
A61K 9/19
A61K 9/08
A61K 47/69
A61K 47/26
Abstract:
The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.

Antimicrobial Compositions

View page
US Patent:
20200022971, Jan 23, 2020
Filed:
May 29, 2019
Appl. No.:
16/425580
Inventors:
- Morristown NJ, US
Eric S. BURAK - East Haddam CT, US
David S. DRESBACK - Stonington CT, US
Danielle B. LORD - Hamden CT, US
International Classification:
A61K 31/4709
A61K 47/26
A61K 9/00
A61K 47/40
A61K 47/18
A61K 47/69
A61K 9/08
A61K 9/19
A61K 31/47
B82Y 5/00
Abstract:
The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.

Lyophilized Compositions Containing A Metap-2 Inhibitor

View page
US Patent:
20170273932, Sep 28, 2017
Filed:
Aug 24, 2015
Appl. No.:
15/505308
Inventors:
- Boston MA, US
Nancy Harper - Taunton MA, US
David Dresback - Stonington CT, US
Thomas Crawford - Essex CT, US
Gary Elliott - Portland ME, US
Walter Lunsmann - Harvard MA, US
Grant Wilson - San Diego CA, US
Jose Casillas - Chula Vista CA, US
International Classification:
A61K 31/336
A61K 47/10
A61K 47/26
A61K 47/14
A61K 9/00
A61K 47/24
A61K 47/32
A61K 47/38
A61K 47/02
A61K 9/19
A61K 47/44
Abstract:
This disclosure features compositions (e.g., re-constitutable solids, such as lyophilized cakes; or liquid compositions, such as solutions or suspensions, e.g., reconstituted lyophilized cakes) that are suitable for subcutaneous administration. The compositions include a crystalline form (e.g., Form A) of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol, free base and one or more pharmaceutically acceptable excipients and/or one or more pharmaceutically acceptable carriers (e.g., one or more bulking agents; one or more dispersing agents; one or more buffers; one or more suspending agents; water, e.g., water for injection (“WFI”)).

Antimicrobial Compositions

View page
US Patent:
20160235736, Aug 18, 2016
Filed:
Feb 12, 2016
Appl. No.:
15/042886
Inventors:
- New Haven CT, US
Eric S. BURAK - East Haddam CT, US
David S. DRESBACK - Stonington CT, US
Danielle B. LORD - Hamden CT, US
International Classification:
A61K 31/4709
A61K 9/00
A61K 47/26
A61K 47/48
A61K 47/40
A61K 47/18
Abstract:
The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.

Pharmaceutical Compositions

View page
US Patent:
20140094463, Apr 3, 2014
Filed:
Nov 1, 2011
Appl. No.:
13/882698
Inventors:
Eric S. Burak - East Haddam CT, US
Danping Li - Middlebury CT, US
David S. Dresback - Stonington CT, US
Assignee:
RIB-X PHARMACEUTICALS, INC. - New Haven CT
International Classification:
C07D 413/12
C07D 413/14
C07D 263/22
A61K 47/14
A61K 47/22
US Classification:
5142368, 514376
Abstract:
The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
Control profile
David S Dresback from Stonington, CT, age ~81 Get Report